Burns
Conditions
Interventions
This is a randomized, controlled, two-arm, double-blind clinical trial. Experimental group: 57 burn victims participants will receive 40 mg/kg of intravenous magnesium sulfate diluted in 0.9% sodium c
Sponsors
Fundação de Ensino e Pesquisa em Ciências da Saúde/ FEPECS/ SES/ DF
Hospital Regional da Asa Norte
Eligibility
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: Patients admitted to the burn treatment unit who will undergo balneotherapy and dressing change; of both genders; age between 18 and 59 years; classified in physical states I and II (according to the classification of the American Society of Anesthesiology); with 10 -20% burned body surface area; with more than 24 hours and less than 72 hours of hospitalization
Exclusion criteria
Exclusion criteria: Readmitted patients; outpatient balneotherapy/dressing; illicit drug users; previous pain syndromes; cognitive impairment; allergic to any component of the study; psychiatric disorders; pharmacodermia; myasthenia gravis; heart disease; hypermagnesemia; pregnant women; lactating women and creatinine elevation (>1.2 mg/dl)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Obtain the average pain scores using the numerical verbal scale (0-10) before Magnesium Sulfate infusion, after balneotherapy, after dressing change, 30 and 60 minutes of stay in the recovery room and compare it between the experimental and control group. ;Obtain the average of total morphine consumption and compare it between the experimental and control groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Describe side effects related to Magnesium Sulfate infusion, as well as its frequency. | — |
Countries
Brazil
Contacts
Public ContactJoadyson Barbosa
Hospital Regional da Asa Norte
Outcome results
None listed